Lionco Pharmaceutical Group Co.,Ltd. (SHSE: 603669)
Health Care · Pharmaceuticals · CN
CN¥5.48
-12.88% today · -12.5% 1Y
Lionco Pharmaceutical Group Co.,Ltd. (SHSE: 603669) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $573.52M and employs 284 people.
Over the last twelve months the share price has lost 12.5%, trading between 4.01 and 8.40.
Tweenvest scores Lionco Pharmaceutical Group Co.,Ltd. across four factors: quality 55/100, value 61/100, growth 0/100. Its strongest factor is value.
603669 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $573.52M
- Revenue (TTM)
- $60.11M
- P/E
- —
- EPS
- -0.20
- Dividend yield
- —
- Beta (5Y)
- 0.24
- 52-week high
- CN¥8.40
- 52-week low
- CN¥4.01
- Avg volume (3M)
- —
- Shares outstanding
- 703.54M
- Employees
- 284
- Next earnings
- —
About Lionco Pharmaceutical Group Co.,Ltd.
Lionco Pharmaceutical Group Co., Ltd., in collaboration with its various subsidiaries, actively participates in the entire lifecycle of pharmaceutical products within China, from initial research and development to manufacturing and sales. The company boasts a comprehensive portfolio of therapeutic solutions, encompassing medications for nutritional support, antimicrobial and antiviral treatments, digestive disorders, cardiovascular health, detoxification, and anti-tumor therapies, alongside other specialized products. Furthermore, it maintains dedicated research institutes that focus specifically on the advancement of chemical, natural, and biological drugs. Established in 2003, Lionco Pharmaceutical Group Co., Ltd. is headquartered in Shannan, China.
- ISIN
- CNE1000022R8
- Founded
- 2003
- Listed since
- May 28, 2015
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.35 | +0.16% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.90 | -1.25% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.15 | +0.29% |
Figures last refreshed Aug 18, 2026.